🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
161.20
+1.77 (1.11%)
At close: Nov 20, 2026, 4:00 PM EST
165.79
+4.59 (2.85%)
After-hours: Nov 20, 2026, 7:58 PM EST

Revolution Medicines Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
615.91383.75543.06696.15161.41108.5
Short-Term Investments
3,0351,6421,7461,157483.53468.56
Cash & Short-Term Investments
3,6512,0262,2891,853644.94577.05
Cash Growth
89.04%-11.52%23.55%187.31%11.77%30.93%
Receivables
230.72--1.254.675.93
Prepaid Expenses
83.5749.3638.3325.0710.576.79
Total Current Assets
3,9772,0752,3281,879660.19589.77
Property, Plant & Equipment
160.02165.28141.82100.0173.7471.24
Goodwill
14.6114.6114.6114.6114.6114.61
Other Intangible Assets
55.4755.856.6757.7458.8159.88
Long-Term Deferred Charges
-----0.5
Other Long-Term Assets
96.7143.7917.5710.064.592
Total Assets
4,3042,3552,5582,062811.93737.99

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
100.6664.6254.4361.7921.3114.06
Accrued Expenses
342.9201.4896.0370.828.9427.41
Current Portion of Leases
9.3816.4712.877.376.776.21
Current Unearned Revenue
----4.4612.36
Other Current Liabilities
22.737.860.583.90.510.31
Total Current Liabilities
475.67290.42163.91143.8561.9860.35
Long-Term Debt
1,060268.45----
Long-Term Leases
141.84142.23122.9780.5857.4360.42
Long-Term Unearned Revenue
-----6.57
Long-Term Deferred Tax Liabilities
-2.352.353.127.037.44
Other Long-Term Liabilities
224.3119.753.867.970.30.63
Total Liabilities
1,902723.21293.1235.51126.74135.42

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.020.020.020.010.01
Additional Paid-In Capital
6,7914,4974,0022,9631,3881,056
Retained Earnings
-4,375-2,869-1,738-1,138-701.34-452.64
Comprehensive Income & Other
-14.673.241.320.54-1.78-0.38
Total Common Equity
2,4021,6312,2651,826685.19602.57
Shareholders' Equity
2,4021,6312,2651,826685.19602.57
Total Liabilities & Equity
4,3042,3552,5582,062811.93737.99

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,211427.15135.8487.9464.2166.63
Net Cash (Debt)
2,4401,5992,1531,765580.74510.42
Net Cash Growth
60.89%-25.77%22.01%203.93%13.78%25.08%
Net Cash Per Share
11.928.4112.8415.607.207.01
Filing Date Shares Outstanding
216.29198.17185.91164.6990.4974.19
Total Common Shares Outstanding
216.25197185.9164.6790.4174.14
Working Capital
3,5011,7852,1641,735598.2529.42
Book Value Per Share
11.118.2812.1911.097.588.13
Tangible Book Value
2,3311,5612,1941,754611.77528.08
Tangible Book Value Per Share
10.787.9211.8010.656.777.12
Machinery
46.7739.3831.4428.0921.7414.98
Construction In Progress
0.30.050.390.51-0.13
Leasehold Improvements
22.6622.2814.2811.9511.47.25
SEC Filings: 10-K · 10-Q